An Additional LDL-Lowering Effect of Amlodipine; Not Only an Antihypertensive?

By Arslan Zekeriya   Ay Seyit Ahmet   Karaman Murat   Cakar Mustafa   Celik Turgay   Balta Sevket   Akhan Muharrem   Sarlak Hakan   Arslan Erol   Demirbas Seref   Demirkol Sait   Bulucu Fatih   Saglam Kenan  

Clinical and Experimental Hypertension, Vol. 35, Iss. 6, 2013-10 ,pp. : 449-453

Informa Healthcare

Access to resources Recommend Favorite

Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 173-177

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 820-830

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glucose and LDL Lowering: The Need for Intensive Therapy

By  

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-01 ,pp. : 687-689

Bentham Science Publishers

Access to resources Recommend Favorite